Devices › Lens, intraocular, toric optics
Device brand name · Lens intraocular toric optics
Clareon Vivity Toric Extended Vision Hydrophobic IOL: medical device reports filed with FDA
314 reports name it, 2022–2026. Manufacturer given most often on reports: Alcon Laboratories Ireland. Product code MJP.
- 314
- device reports naming the brand
- 0% of all MAUDE reports · about 80 a year
- 119
- reports, 12 months to August 2026
- 112 in the 12 months before
- 48.4%
- classified as malfunction
- 42% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 314 reports that name the brand "Clareon Vivity Toric Extended Vision Hydrophobic IOL" (lens intraocular toric optics), received between August 2022 and August 2026; the manufacturer given most often on reports is Alcon Laboratories Ireland. Spellings of one product vary from report to report.
119 reports arrived in the 12 months to August 2026, close to the 112 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (51.6%) and malfunction (48.4%); across all lens, intraocular, toric optics reports (product code MJP) death is recorded in 0% and malfunction in 42%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are scratched material (13.7%), break (11.8%) and material split, cut or torn (7%). The patient problems coded most often are blurred vision, visual impairment and visual disturbances. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 8,214 reports carrying product code MJP. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Scratched material | 43 | 13.7% | 7.8% |
| Breakthe device broke | 37 | 11.8% | 8.8% |
| Material split, cut or torn | 22 | 7% | 2.2% |
| Device dislodged or dislocated | 16 | 5.1% | 5.9% |
| Material twisted/bent | 16 | 5.1% | 2% |
| Material opacification | 13 | 4.1% | 0.9% |
| Product quality problem | 13 | 4.1% | 1.3% |
| Defective devicethe device was defective | 11 | 3.5% | 2.6% |
| Device difficult to setup or prepare | 9 | 2.9% | 2.8% |
| Material deformation | 9 | 2.9% | 0.9% |
| Failure to deliverthe device did not deliver the dose or item | 6 | 1.9% | 2.5% |
| Crackthe device cracked | 5 | 1.6% | 2.1% |
| Defective component | 5 | 1.6% | 0.6% |
| Malposition of device | 5 | 1.6% | 2% |
| Material discolored | 4 | 1.3% | 3.3% |
| Failure to eject | 3 | 1% | 0.7% |
| Application program problem: power calculation error | 2 | 0.6% | 0.1% |
| Device damaged by another device | 2 | 0.6% | 1% |
| Failure to unfold or unwrap | 2 | 0.6% | 0.6% |
| Inaccurate delivery | 2 | 0.6% | 0.9% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Blurred vision | 87 | 27.7% |
| Visual impairmentreduced vision | 65 | 20.7% |
| Visual disturbances | 35 | 11.1% |
| Diplopia/double vision | 5 | 1.6% |
| Halo | 4 | 1.3% |
| Corneal edema | 3 | 1% |
| Eye paineye pain | 3 | 1% |
| Vitreous floatersfloaters in vision | 3 | 1% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 2 | 0.6% |
| Corneal abrasion | 2 | 0.6% |
| Dry eye(s) | 2 | 0.6% |
| Eye irritationeye irritation | 2 | 0.6% |
| Macular edema | 2 | 0.6% |
| Posterior capsule opacification | 2 | 0.6% |
| Capsular bag tear | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Clareon Vivity Toric Extended Vision Hydrophobic IOL | Product code MJP | All MAUDE reports |
|---|---|---|---|
| Reports | 314 | 8,214 | 26,136,888 |
| Share of that pool | — | 3.8% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 51.6% | 54.5% | 36.2% |
| Classified as malfunction | 48.4% | 42% | 62.3% |
| Filed by the manufacturer | 100% | 99.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MJP
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| AcrySof IQ Toric Singlepiece IOL | 1,767 | 60 | 0% |
| Tecnis Iol | 5,901 | 715 | 0% |
| Clareon Toric Aspheric Hydrophobic Acrylic IOL with AutonoME Delivery System | 567 | 235 | 0% |
| Clareon Toric IOL | 567 | 207 | 0% |
| Clareon PanOptix Toric Trifocal UV Absorbing IOL | 488 | 75 | 0% |
| Clareon PanOptix Toric Trifocal Hydrophobic IOL | 430 | 136 | 0% |
| Clareon Vivity Toric Extended Vision UV Absorbing IOL | 388 | 95 | 0% |
| Clareon Toric UV Absorbing IOL | 309 | 126 | 0% |
| Acrysof Restor Toric Singlepiece Iol | 269 | 0 | 0% |
| Acrysof Iq Toric | 1,905 | 0 | 0% |
| Acrysof Toric | 638 | 0 | 0% |
| Trulign Toric Posterior Chamber Iol | 179 | 0 | 0% |
| CLAREON PANOPTIX PRO Trifocal TORIC UV Absorbing IOL w/AutonoME Delivery System | 150 | 146 | 0% |
| Tecnis | 3,082 | 0 | 0.1% |
| Tecnis Symfony Toric | 1,096 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Clareon Vivity Toric Extended Vision Hydrophobic IOL reports
How many FDA reports name Clareon Vivity Toric Extended Vision Hydrophobic IOL?
314 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 119 in the latest 12 months.
What kinds of events are reported?
injury (51.6%) and malfunction (48.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
scratched material (13.7%), break (11.8%), material split, cut or torn (7%), device dislodged or dislocated (5.1%) and material twisted/bent (5.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Clareon Vivity Toric Extended Vision Hydrophobic IOL was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.